放大圖請點此處
(1) In 2024, the Zhunan aseptic drug product (DP) production line passed the TFDA GMP inspection (including GDP).
(2) In 2019, oncology APIs (Azacitidine, Bortezomib, Fulvestrant, Glucagon, Pemetrexed Disodium Hemipentahydrate, Teriparatide) passed the PIC/S GMP inspection (including GDP).